IBDEI0ZJ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16034,1,3,0)
 ;;=3^Athscl of Bypass Graft of Right Leg w/ Heel/Midfoot Ulcer
 ;;^UTILITY(U,$J,358.3,16034,1,4,0)
 ;;=4^I70.734
 ;;^UTILITY(U,$J,358.3,16034,2)
 ;;=^5007772
 ;;^UTILITY(U,$J,358.3,16035,0)
 ;;=I70.735^^61^765^85
 ;;^UTILITY(U,$J,358.3,16035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16035,1,3,0)
 ;;=3^Athscl of Bypass Graft of Right Leg w/ Oth Part Foot Ulcer
 ;;^UTILITY(U,$J,358.3,16035,1,4,0)
 ;;=4^I70.735
 ;;^UTILITY(U,$J,358.3,16035,2)
 ;;=^5007773
 ;;^UTILITY(U,$J,358.3,16036,0)
 ;;=I70.741^^61^765^80
 ;;^UTILITY(U,$J,358.3,16036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16036,1,3,0)
 ;;=3^Athscl of Bypass Graft of Left Leg w/ Thigh Ulcer
 ;;^UTILITY(U,$J,358.3,16036,1,4,0)
 ;;=4^I70.741
 ;;^UTILITY(U,$J,358.3,16036,2)
 ;;=^5133601
 ;;^UTILITY(U,$J,358.3,16037,0)
 ;;=I70.742^^61^765^77
 ;;^UTILITY(U,$J,358.3,16037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16037,1,3,0)
 ;;=3^Athscl of Bypass Graft of Left Leg w/ Calf Ulcer
 ;;^UTILITY(U,$J,358.3,16037,1,4,0)
 ;;=4^I70.742
 ;;^UTILITY(U,$J,358.3,16037,2)
 ;;=^5133602
 ;;^UTILITY(U,$J,358.3,16038,0)
 ;;=I70.743^^61^765^76
 ;;^UTILITY(U,$J,358.3,16038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16038,1,3,0)
 ;;=3^Athscl of Bypass Graft of Left Leg w/ Ankle Ulcer
 ;;^UTILITY(U,$J,358.3,16038,1,4,0)
 ;;=4^I70.743
 ;;^UTILITY(U,$J,358.3,16038,2)
 ;;=^5133603
 ;;^UTILITY(U,$J,358.3,16039,0)
 ;;=I70.744^^61^765^78
 ;;^UTILITY(U,$J,358.3,16039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16039,1,3,0)
 ;;=3^Athscl of Bypass Graft of Left Leg w/ Heel/Midfoot Ulcer
 ;;^UTILITY(U,$J,358.3,16039,1,4,0)
 ;;=4^I70.744
 ;;^UTILITY(U,$J,358.3,16039,2)
 ;;=^5133604
 ;;^UTILITY(U,$J,358.3,16040,0)
 ;;=I70.745^^61^765^79
 ;;^UTILITY(U,$J,358.3,16040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16040,1,3,0)
 ;;=3^Athscl of Bypass Graft of Left Leg w/ Oth Part Foot Ulcer
 ;;^UTILITY(U,$J,358.3,16040,1,4,0)
 ;;=4^I70.745
 ;;^UTILITY(U,$J,358.3,16040,2)
 ;;=^5133605
 ;;^UTILITY(U,$J,358.3,16041,0)
 ;;=I83.009^^61^765^327
 ;;^UTILITY(U,$J,358.3,16041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16041,1,3,0)
 ;;=3^Varicose Veins of Lower Extremity w/ Ulcer
 ;;^UTILITY(U,$J,358.3,16041,1,4,0)
 ;;=4^I83.009
 ;;^UTILITY(U,$J,358.3,16041,2)
 ;;=^5007972
 ;;^UTILITY(U,$J,358.3,16042,0)
 ;;=N61.1^^61^765^1
 ;;^UTILITY(U,$J,358.3,16042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16042,1,3,0)
 ;;=3^Abscess of Breast & Nipple
 ;;^UTILITY(U,$J,358.3,16042,1,4,0)
 ;;=4^N61.1
 ;;^UTILITY(U,$J,358.3,16042,2)
 ;;=^5138937
 ;;^UTILITY(U,$J,358.3,16043,0)
 ;;=L03.213^^61^765^96
 ;;^UTILITY(U,$J,358.3,16043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16043,1,3,0)
 ;;=3^Cellulitis Periorbital
 ;;^UTILITY(U,$J,358.3,16043,1,4,0)
 ;;=4^L03.213
 ;;^UTILITY(U,$J,358.3,16043,2)
 ;;=^259555
 ;;^UTILITY(U,$J,358.3,16044,0)
 ;;=L90.0^^61^765^170
 ;;^UTILITY(U,$J,358.3,16044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16044,1,3,0)
 ;;=3^Lichen Sclerosus et Atrophicus
 ;;^UTILITY(U,$J,358.3,16044,1,4,0)
 ;;=4^L90.0
 ;;^UTILITY(U,$J,358.3,16044,2)
 ;;=^70699
 ;;^UTILITY(U,$J,358.3,16045,0)
 ;;=N63.20^^61^765^172
 ;;^UTILITY(U,$J,358.3,16045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16045,1,3,0)
 ;;=3^Lump,Left Breast,Unspec Quadrant
 ;;^UTILITY(U,$J,358.3,16045,1,4,0)
 ;;=4^N63.20
 ;;^UTILITY(U,$J,358.3,16045,2)
 ;;=^5151524
 ;;^UTILITY(U,$J,358.3,16046,0)
 ;;=N63.10^^61^765^173
